Dengler, J., Topaly, J., Frühauf, S., Hensel, M., & Ho, A. D. (2002). Level of CD 20-expression and efficacy of Rituximab treatment in patients with resistant or relapsing B-cell prolymphocytic leukemia and B-cell chronic lymphocytic leukemia. Leukemia and lymphoma, 43(1), . https://doi.org/10.1080/10428190210178
Chicago-Zitierstil (17. Ausg.)Dengler, Jolanta, Julian Topaly, Stefan Frühauf, Manfred Hensel, und Anthony Dick Ho. "Level of CD 20-expression and Efficacy of Rituximab Treatment in Patients with Resistant or Relapsing B-cell Prolymphocytic Leukemia and B-cell Chronic Lymphocytic Leukemia." Leukemia and Lymphoma 43, no. 1 (2002). https://doi.org/10.1080/10428190210178.
MLA-Zitierstil (9. Ausg.)Dengler, Jolanta, et al. "Level of CD 20-expression and Efficacy of Rituximab Treatment in Patients with Resistant or Relapsing B-cell Prolymphocytic Leukemia and B-cell Chronic Lymphocytic Leukemia." Leukemia and Lymphoma, vol. 43, no. 1, 2002, https://doi.org/10.1080/10428190210178.